Lifecore Biomedical, Inc. Stock News

Lifecore (LFCR) ends a year-long strategic review and will continue its operations on a stand-alone basis. The company also names a new CEO effective from May 20.

Lifecore Biomedical (LFCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength

Lifecore Biomedical (LFCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.01 per share a year ago.

CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), t

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Qiagen (QGEN) or Lifecore Biomedical (LFCR). But which of these two stocks is more attractive

Lifecore Biomedical, Inc. is running a sale process. Laughing Water Capital believes upside of 150% is possible over the next three months. The Company's assets are highly strategic, and thus attracti

Lifecore Biomedical, Inc. (NASDAQ:LFCR ) Q3 2023 Earnings Conference Call June 1, 2023 8:30 AM ET Company Participants Jim Hall - President John Morberg - CFO Conference Call Participants Operator Goo

Lifecore Biomedical jumped 50% yesterday after the company finally dispelled the previous going concern risk. Despite the share price jump, there are two other short-term catalysts here that could pro

Shares of Lifecore Biomedical on Monday climbed 19% to $6.40 in after-hours trading after the company said it secured a new $150 million financing agreement with its long-term customer Alcon.

CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), to

ARGO, PFSI and LFCR have been added to the Zacks Rank #5 (Strong Sell) List on May 15, 2023.

Lifecore: Extraordinary Upside Likely Despite Bankruptcy Concerns.

Penny stocks to buy according to 3 analysts. The post 3 Penny Stocks To Buy According To Analysts, Targets Up To %170 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c

Use these tips for finding high potential penny stocks The post High-Potential: A Short Guide to Penny Stock Investing appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.